Neuralab
L5 pyramidal neuron, mouse cortex, rendered in ASCIIt = 0.0 ms

Neuralab is building predictive neuromodulation.

We build AI that predicts how a patient's brain circuit will respond to stimulation, before the first pulse. Our first application is deep brain stimulation for Parkinson's disease.

Neuroscience has spent two decades mapping how the brain is wired. Diffusion MRI traces the large fibre bundles between regions in living people.1 Electron microscopy has mapped about 150 million synapses in a single cubic millimetre of human cortex.2 Cell atlases list the types of neurons in each region.3 These maps are extraordinary, and on their own they still do not tell you what a circuit will do.

A wiring diagram is static. The same connections can produce very different activity depending on neuromodulators, cell state, medication and disease.4 Human connectomes from imaging are coarse and are usually averaged across many people,5 and synapse-level maps come from small pieces of tissue that will never be stimulated.2 When a stimulating lead sits in a patient's subthalamic nucleus, the map can say which pathways run nearby. It cannot say how this patient's circuit will respond to 2 milliamps at 130 hertz.

That is the problem we work on. We use the connectome as a scaffold and build, patient by patient, a circuit model of how activity moves through it when it is perturbed. A circuit model is only useful if it predicts what happens next, so prediction is how we build it and how we judge it.

The data to do this has only recently started to exist. Sensing-enabled stimulators now record local field potentials from the same leads they stimulate through.6 Every change of setting is a perturbation with a recorded response, in a living human brain, repeated in every implanted patient. Very little of it is used today.

Each prediction can be checked. The model proposes a setting, the device records how the circuit responds, and the next prediction starts from a better model of that patient.

Why predict, and why now

The brain has started reporting back.

In 2025 the FDA approved the first adaptive deep brain stimulation system, which records from the same leads it stimulates through.6,7 For the first time, stimulation of a human circuit can come with a recorded response, day and night.

Reacting is not the same as choosing.

Today's closed-loop devices follow a single signal and turn stimulation up or down when it crosses a line.6 A device that can predict how the circuit will respond can choose where, how and when to stimulate, before the patient feels the consequences of a wrong guess.

The options have outgrown trial and error.

Directional leads, new waveforms and new targets have multiplied the settings a clinician could try,8 while each adjustment is still tried by hand, one clinic visit at a time.9 A search that large needs a model to narrow it before anyone is stimulated.

The models are finally ready.

Methods that learn from incomplete, multi-track records, which already work on proteins and language,10 can now be trained on patients whose data is never complete. Prediction is how those models are tested: they either forecast the response or they do not.

This is a long project with many unknowns. If you work on machine learning for neural data, run a DBS program, build stimulation hardware, or want to spend years on this problem, get in touch.

Sources
  1. Jbabdi S, Johansen-Berg H. Tractography: where do we go from here? Brain Connectivity 1(3), 2011. link
  2. Shapson-Coe A, et al. A petavoxel fragment of human cerebral cortex reconstructed at nanoscale resolution. Science 384, 2024. link
  3. Siletti K, et al. Transcriptomic diversity of cell types across the adult human brain. Science 382, 2023. Yao Z, et al. A high-resolution transcriptomic and spatial atlas of cell types in the whole mouse brain. Nature 624, 2023. link 1 link 2
  4. Bargmann CI, Marder E. From the connectome to brain function. Nature Methods 10, 2013. Marder E. Neuromodulation of neuronal circuits: back to the future. Neuron 76, 2012. link 1 link 2
  5. Horn A, et al. Connectivity predicts deep brain stimulation outcome in Parkinson disease. Annals of Neurology 82, 2017 (normative, group-average connectome). link
  6. Medtronic. Medtronic earns U.S. FDA approval for the world's first adaptive deep brain stimulation system for people with Parkinson's. Press release, 24 February 2025. link
  7. American Journal of Managed Care. Adaptive deep brain stimulation technology receives FDA approval for Parkinson disease. 26 February 2025. link
  8. Programming directional deep brain stimulation in Parkinson's disease. Stereotactic and Functional Neurosurgery 99(6), 2021. See also: Deep brain stimulation in movement disorders: recent advances and future directions. Practical Neurology, 2023. link 1 link 2
  9. University of Florida Fixel Institute. Impact of image-guided programming on initial DBS clinic visit times and outcomes. Abstract, 2023. link
  10. Devlin J, et al. BERT: pre-training of deep bidirectional transformers for language understanding. arXiv:1810.04805, 2018. Lin Z, et al. Evolutionary-scale prediction of atomic-level protein structure with a language model. Science 379, 2023. link 1 link 2